药物经济学

  • 网络Pharmacoeconomics;Pharmaceutical Economics;pharmaco economics;pharmaco-economics
药物经济学药物经济学
  1. 运用Markov模型进行药物经济学评价的方法概述及国外研究实例分析

    A Review of the Method of Performing Pharmacoeconomics Evaluation Using Markov Model and Analysis of Overseas Cases

  2. 方法运用药物经济学成本-效果分析法,对进口奥曲肽(A组)、国产奥曲肽(B组)治疗方案进行回顾性分析。

    Methods The cost-effectiveness method in pharmacoeconomics was adopted in the retrospective analysis of the following two treatment schemes : import octreotide in group A , homemade octreotide in group B.Results The curative effects of the two drug treatment regimes were close ( P > 0.05 ) .

  3. 目的探讨单剂量头孢曲松和头孢呋辛连用3d预防胃肠手术部位感染的效果并进行药物经济学分析。

    Objective To compare the effects and pharmacoeconomics of single-dose of ceftriaxone versus 3-day cefuroxime prophylaxis in patients undergoing gastric or colorectal resection .

  4. 方法:运用药物经济学成本效果分析法,对A,B2组方案进行比较。

    Methods : Regimen A and B were compared by cost-effectiveness analysis .

  5. 雷贝拉唑、阿莫西林和替硝唑组成的三联5日疗法是一种短程、安全、有效符合药物经济学要求的根除HP和治疗消化性溃疡的方案。

    The 5-day rabeprazole based triple therapy is a short-term , effective , safe and lower-therapeutic-cost regiment for H.pylori eradication and peptic ulcer therapy .

  6. 方法将100例急性盆腔炎患者随机分为A组(丹参注射液+青霉素注射液+甲硝唑注射液)、B组(青霉素注射+甲硝唑注射液)2组,运用药物经济学方法比较其成本-效果。

    Methods 100 cases of acute pelvic inflammatory disease were randomly divided into 2 groups : group A and group B.The cost and effectiveness of the 2 groups were compared by using pharmaceutical economics .

  7. 目的评价氨苄西林-舒巴坦组(A组)、头孢哌酮组(B组)、左氧氟沙星组(C组)三种方案对治疗社区获得性肺炎药物经济学成本与效果。

    OBJECTIVE To evaluate the cost-effectiveness of three therapeutic schemes , ampicillin-sulbactam injection ( A ), cefoperazone injection ( B ) and levofloxacin injection ( C ) in treatment of the community acquired pneumonia infections .

  8. 方法:186例细菌性肺炎患者随机分为A、B、C组,分别给予头孢噻肟钠、左氧氟沙星、氯唑西林钠治疗,观察各组疗效、不良反应,并运用药物经济学方法进行分析。

    METHODS : 186 patients with bacterial pneumonia were selected and randomly divided into 3 groups . Group A were treated with cefotaxime , Group B with levofloxacin and Group C with cloxacillin sodium . The curative effects and adverse drug reactions were observed and analyzed by pharmacoeconomics method .

  9. 目的:从药物经济学角度,观察比较TC(TAX+CBP)、GP(GEM+DDP)和NP(NVB+DDP)联合化疗方案的合理性。

    OBJECTIVE : To observe and compare the rationality among three combined chemotherapy regimens-TC ( TAX + CBP ), GP ( GEM + DDP ) and NP ( NVB + DDP ) from the perspective of pharmacoeconomics .

  10. 方法:74例肺癌患者,根据不同治疗方案随机分为A、B和C3组,运用药物经济学成本-效果分析方法对3组治疗方案进行回顾性分析、评价。

    METHODS : 74 patients with lung cancer were randomly divided into three groups group A 、 B and C based on different regimens . Then retrospective analysis and evaluation for these chemotherapy regimens was performed by using cost effectiveness analysis of pharmacoeconomics .

  11. 方法:采用DDDs分析法及药物经济学方法对1999年~2000年北京地区消化系统药物的销售金额和应用频度等进行分析。

    METHODS : To analyse the situation of the drugs used in 1999-2000 in respect to the sum of money and frequency of use by the method of DDDs analysis and pharmacoeconomics .

  12. 目的初步探讨奥替溴铵(斯巴敏)、匹维溴铵(得舒特)、马来酸曲美布汀(舒丽启能)和酪酸菌(米雅BM)治疗肠易激综合征的药物经济学。

    Aim To evaluate the economics of otilonium Br ( Spasmomen ), pinaverium Br ( Dicetl ), trimebutine maleate ( Cerekinon ) and clostridium butyricum ( Miya-BM ) in the treatment of irritable bowel syndrome patients .

  13. 方法:96例支原体肺炎(MP)患者随机分为序贯疗法治疗组(A)和全程静脉注射给药组(B),运用药物经济学的成本-效果分析方法进行比较。

    Methods : 96 cases of mycoplasmal pneumonia patients were divided into the sequential therapy group ( A ) and the group of intravenous administration in the whole range ( B ) . A comparison was made between these two groups in the way of pharmacoeconomics cost-effectiveness analysis .

  14. 结论从药物经济学角度看,治疗鼻咽癌放疗引起的口腔黏膜炎时选用复方维生素B12效价比相对较高。

    Conclusion From the viewpoint of pharmacoeconomics , it seems preferable to use compound vitamin B_12 with a higher effect / cost ratio in the treatment of oral mucositis caused by radiotherapy in patients with NPC .

  15. 单剂量头孢曲松和多剂量头孢呋辛预防手术部位感染效果和药物经济学研究

    Single-dose ceftriaxone versus multiple-dose cefuroxime for prophylaxis of surgical site infection

  16. 依那普利有3篇针对心衰患者的药物经济学研究,显示依那普利治疗心衰病人经济学效益明确。

    Studies in patients with heart failure showed enalaprol is economical .

  17. 药物经济学评价中中成药有效性问题的探讨

    Efficacy Evaluation of Chinese Traditional Medicine by the Theory of Pharmacoeconomics

  18. 方法基于医疗保险角度开展药物经济学评价研究。

    Methods Cost effectiveness was conducted from social health insurance perspective .

  19. 安奇治疗小儿呼吸道感染的临床和药物经济学分析

    Clinical and pharmaco-economic analysis of Anqi therapy in children with respiratory infection

  20. 3种抗生素治疗同一种疾病的药物经济学研究

    Three Types of Antibiotic Treatment of A Disease with the Drug Economics

  21. 结论:药物经济学研究可以合理利用卫生资源。

    Conclusion : Study on pharmacoeconomics can distribute rationally our sanitary resources .

  22. 方法根据药物经济学基本理论及研究方法。

    Methods According to the basic theory and research methods of pharmacoeconomics .

  23. 运用药物经济学的成本&效果分析方法进行评价。

    The data were evaluated with cost - effectiveness analysis .

  24. 5种感冒药的药物经济学及用药风险分析

    Pharmaceutical economics research and risks analysis of five cold drugs

  25. 三种方案治疗慢性盆腔炎的药物经济学分析

    Economical Analysis of Three Therapy on the Chronic Pelvic Inflammation

  26. 药物经济学评价需求、方法与指南研究

    Study on Demands , Evaluation Methods and Guidelines of Pharmacoeconomics

  27. 方法运用药物经济学原理对三种红霉素衍生物类抗生素治疗上呼吸道感染的方案进行成本效果分析。

    METHOD Using cost effectiveness analysis , three erythromycin derivatives were evaluated .

  28. 头孢曲松与头孢哌酮治疗儿科感染的药物经济学分析

    Pharmacoeconomics analysis on ceftriaxone and cefoperazone in treatment of children infectious disease

  29. 药物经济学前沿研究进展

    Talking Abour the Frontier Development of the Medicine Economics Research

  30. 结果与结论:药物经济学可作为药品定价和补偿的参考依据。

    RESULTS & CONCLUSION : Pharmacoeconomics can aid for drug policy decision .